N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride, 97.0%, 1g

2,6-Dibromoanthraquinone, 95.0%, 5g

(S)-3-Acetyl-4-isopropylthiazolidine-2-thione, 97%, 5g

Ethyl-2,5-dimethylbenzoylformate, 98.0%, 5g

(S)-3-Methylpyrrolidin-3-ol hydrochloride, 95.0%, 1g

6,7,8,9-Tetrahydrospiro[benzo[7]annulene-5,4'-imidazolidine]-2',5'-dione, 95+%, 100mg

5-(Difluoromethoxy)-6-methylpyridin-2-amine, 98%, 1g

Boîte cryogénique ROTILABO® sans division, bleue, Hauteur, 52 mm, 5 Pièce(s)

3-(2-((1R,4aS,5R,8aS)-5,8a-Dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one, 98%, 25mg

5-Bromo-2-chlorobenzaldehyde, 98.0%, 10g

2-Indanone, 96.0%, 5g

4-Hydroxymethylthiazole, 95.0%, 1g

5-Methyl-2 H -[1,2,3]triazole-4-carboxylic acid, 95.0%, 1g